<DOC>
	<DOCNO>NCT00127582</DOCNO>
	<brief_summary>This prospective multicentric Italian study evaluate arrhythmic risk myotonic dystrophy type 1 .</brief_summary>
	<brief_title>RAMYD Study - Evaluation Arrhythmic Risk Myotonic Dystrophy</brief_title>
	<detailed_description>Myotonic dystrophy type 1 ( DM1 , Steinert disease ) multisystem disorder affect , beside muscle , several organ , include heart . Cardiac involvement represent major problem clinical management patient , cardiac complication represent one primary cause premature death DM1 . In particular high incidence sudden death , range 2 30 % case , far principally relate development conduction block . However , literature report sudden death patient implanted pacemaker , well spontaneous ventricular tachycardia would suggest potential etiologic role also ventricular arrhythmia . The lack clinical research study conduct large number patient make available definite data regard etiology epidemiology arrhythmic event DM1 . For reason , considerable topic , prognostic stratification arrhythmic risk clinical management life-threatening arrhythmia DM1 patient , still undefined . To clarify issue , investigator propose clinical research study perform large cohort DM1 patient enrol multicenter collaboration also involve 5 cardiological-neurological Italian centre . Aims study : - To estimate incidence arrhythmias characterize brady-tachyarrhythmic mechanism underlie occurrence cardiac sudden death DM1 ; - To verify statistical analysis reliability data obtain non invasive invasive diagnostic procedure index useful estimate arrhythmic risk DM1 ; - To identify adequate therapeutic guideline order prevent occurrence life-threatening arrhythmia . The protocol study include : 1 . Clinical-genetic evaluation ; 2 . Non invasive invasive diagnostic cardiac procedure ; 3 . The use device diagnostic therapeutic follow-up .</detailed_description>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<criteria>Patient affect myotonic dystrophy type I ( MD1 ) . Patient willing provide sign informed consent . Age &lt; 18 year old &gt; 70 year old . Ischemic cardiomyopathy Cardiomyopathy due chronic excess alcohol consumption ( &gt; 100 g\day ) Congenital heart disease Acquired valvular heart disease Metabolic cardiomyopathy : thyrotoxicosis , hypothyroidism , adrenal cortical insufficiency , pheochromocytoma , acromegaly Familiar storage infiltrative disease ( hemochromatosis , glycogen storage , Hurler â€™ syndrome , NiemannPick disease ; primary , secondary , familial hereditary cardiac amyloidoses ) Systemic disease ( connective tissue disorder ; sarcoidosis ) Peripartum cardiomyopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>Myotonic dystrophy type 1</keyword>
	<keyword>Sudden cardiac death</keyword>
	<keyword>Ventricular tachyarrhythmias</keyword>
	<keyword>Bradyarrhythmias</keyword>
</DOC>